Table 1.
Country (name of registry) | Quality variables |
||||
---|---|---|---|---|---|
Comparability A, B, C, D, E | Validity A, B, C, D, E | Timeliness A, B | Completeness A, B, C | Total | |
UK (National Cancer Registry)14 | 5 | 4 | 2 | 3 | 14 |
Botswana* | 0 | 0 | 1 | 0 | 1 |
Burkina Faso (Ouagadougou)* | 0 | 2 | 1 | 0 | 3 |
Cameroon (Yaounde)* | 0 | 1 | 1 | 0 | 2 |
Congo (Brazzaville)* | 0 | 1 | 1 | 0 | 2 |
Cote d'Ivoire (Abidjan)*16 | 1 | 3 | 1 | 1 | 6 |
Gabon (Gabon)*17 | 0 | 1 | 1 | 0 | 2 |
Guinea (Conakry)*18 | 1 | 2 | 1 | 0 | 4 |
Kenya (Eldoret)*19 | 1 | 2 | 1 | 0 | 4 |
Kenya (Nairobi)* | 0 | 1 | 1 | 0 | 2 |
Malawi (Blantyre)*20,21 | 1 | 2 | 1 | 1 | 5 |
Mali (Bamako)*†‡ | 0 | 3 | 1 | 1 | 5 |
Namibia* | 0 | 2 | 1 | 1 | 4 |
Niger (Niamey)* | 0 | 2 | 1 | 1 | 4 |
Nigeria (Ibadan)*22,23 | 1 | 3 | 1 | 1 | 6 |
Nigeria (Ilorin)*22,23 | 1 | 1 | 1 | 0 | 3 |
Rwanda (Butare)*24 | 1 | 2 | 1 | 0 | 4 |
South Africa (South Africa)*25,26 | 0 | 2 | 1 | 1 | 4 |
Swaziland* | 0 | 2 | 1 | 1 | 4 |
Tanzania (Kilimanjaro)* | 0 | 1 | 1 | 0 | 2 |
Tanzania (Dar Es Salam)* | 0 | 1 | 1 | 0 | 2 |
The Gambia*†‡27–30 | 4 | 5 | 1 | 1 | 11 |
Uganda (Kampala)*†‡31–35 | 2 | 4 | 2 | 1 | 9 |
Uganda (Mbarara)*36 | 0 | 1 | 1 | 0 | 2 |
Zambia* | 0 | 1 | 1 | 0 | 2 |
Zimbabwe (Harare, black population)*†‡37–39 | 2 | 3 | 1 | 1 | 7 |
Zimbabwe (Bulawayo district)* | 0 | 0 | 1 | 0 | 1 |
IARC, Cancer in Africa (2003).
†IARC, Cancer in 5 Continents IX (2007).
‡IARC, Cancer in 5 Continents VIII (2002).
All other sources listed in Appendix 2.